Font size  A-  A  A+

Dife Logo

Printversion of:
Status: 06.06.2020 16:41:50

Image Gastrointestinal Microbiology

Department of Gastrointestinal Microbiology (GAMI)


Total publications: 202

Sorting by year and alphabetically by first author

Department of Gastrointestinal Microbiology

Original Papers

Mandić, A. D., Woting, A., Jaenicke, T., Sander, A., Sabrowski, W., Rolle-Kampcyk, U., von Bergen, M., Blaut, M.: Clostridium ramosum regulates enterochromaffin cell development and serotonin release. Sci. Rep. 9(1):1177 (2019).

Ring, C., Klopfleisch, R., Dahlke, K., Basic, M., Bleich, A., Blaut, M.: Akkermansia muciniphila strain ATCC BAA-835 does not promote short-term intestinal inflammation in gnotobiotic interleukin-10-deficient mice. Gut Microbes 10, 188-203 (2019).

Braune, A., Blaut, M.: Evaluation of inter-individual differences in gut bacterial isoflavone bioactivation in humans by PCR-based targeting of genes involved in equol formation. J. Appl. Microbiol. 124, 220-231 (2018).

Braune, A., Blaut, M.: Catenibacillus scindens gen. nov., sp. nov., a C-deglycosylating human intestinal representative of the Lachnospiraceae. Int. J. Syst. Evol. Microbiol. 68, 3356-3361 (2018).

Woting, A., Blaut, M.: Small intestinal permeability and gut-transit time determined with low and high molecular weight fluorescein isothiocyanate-dextrans in C3H mice. Nutrients 10(6): 685 (2018).

Weitkunat, K., Stuhlmann, C., Postel, A., Rumberger, S., Fankhänel, M., Woting, A., Petzke, K. J., Gohlke, S., Schulz, T. J., Blaut, M., Klaus, S., Schumann, S.: Short-chain fatty acids and inulin, but not guar gum, prevent diet-induced obesity and insulin resistance through differential mechanisms in mice. Sci. Rep. 7: 6109 (2017).

Braune, A., Engst, W., Blaut, M.: Identification and functional expression of genes encoding flavonoid O- and C-glycosidases in intestinal bacteria. Environ. Microbiol. 18, 2117-2129 (2016).

Braune, A., Engst, W., Elsinghorst, P. W., Furtmann, N., Bajorath, J., Gütschow, M., Blaut, M.: Chalcone isomerase from Eubacterium ramulus catalyzes the ring contraction of flavanonols. J. Bacteriol. 198, 2965-2974 (2016).

Weitkunat, K., Schumann, S., Nickel, D., Kappo, K. A., Petzke, K. J., Kipp, A. P., Blaut, M., Klaus, S.: Importance of propionate for the repression of hepatic lipogenesis and improvement of insulin sensitivity in high-fat diet-induced obesity. Mol. Nutr. Food Res. 60, 2611-2621 (Open Access) (2016).

Budnowski, J., Hanske, L., Schumacher, F., Glatt, H., Platz, S., Rohn, S., Blaut, M.: Glucosinolates are mainly absorbed intact in germfree and human microbiota-associated mice. J. Agric. Food Chem. 63, 8418-8428 (2015).

Kläring, K., Just, S., Lagkouvardos, I., Hanske, L., Haller, D., Blaut, M., Wenning, M., Clavel, T.: Murimonas intestini gen. nov., sp. nov., an acetate-producing bacterium of the family Lachnospiraceae isolated from the mouse gut. Int. J. Syst. Evol. Microbiol. 65, 870-878 (Open Access) (2015).

Weitkunat, K., Schumann, S., Petzke, K. J., Blaut, M., Loh, G., Klaus, S.: Effects of dietary inulin on bacterial growth, short-chain fatty acid production and hepatic lipid metabolism in gnotobiotic mice. J. Nutr. Biochem. 26, 929-937 (2015).

Woting, A., Pfeiffer, N., Hanske, L., Loh, G., Klaus, S., Blaut, M.: Alleviation of high fat diet-induced obesity by oligofructose in gnotobiotic mice is independent of presence of Bifidobacterium longum. Mol. Nutr. Food Res. 59, 2267-2278 (Open Access) (2015).

Foerster, J., Maskarinec, G., Reichardt, N., Tett, A., Narbad, A., Blaut, M., Boeing, H.: The influence of whole grain products and red meat on intestinal microbiota composition in normal weight adults: A randomized crossover intervention trial. PLoS ONE 9(10): e109606 (Open Access) (2014).

Schumann, S., Alpert, C., Engst, W., Klopfleisch, R., Loh, G., Bleich, A., Blaut, M.: Mild gut inflammation modulates the proteome of intestinal Escherichia coli. Environ. Microbiol. 16, 2966-2979 (2014).

Slezak, K., Krupova, Z., Rabot, S., Loh, G., Levenez, F., Descamps, A., Lepage, P., Doré, J., Belllier, S., Blaut, M.: Association of germ-free mice with a simplified human intestinal microbiota results in a shortened intestine. Gut Microbes 5, 176-182 (2014).

Woting, A., Pfeiffer, N., Loh, G., Klaus, S., Blaut, M.: Clostridium ramosum promotes high-fat diet-induced obesity in gnotobiotic mouse models. mBio 5(5):e01530-14 (Open Access) (2014).

Brodziak, F., Meharg, C., Blaut, M., Loh, G.: Differences in mucosal gene expression in the colon of two inbred mouse strains after colonization with commensal gut bacteria. PLoS ONE 8(8):e72317 (2013).

Budnowski, J., Hanschen, F. S., Lehmann, C., Haack, M., Brigelius-Flohé, R., Kroh, L. W., Blaut, M., Rohn, S., Hanske, L.: A derivatization method for the simultaneous detection of glucosinolates and isothiocyanates in biological samples. Anal. Biochem. 441, 199-207 (2013).

Ganesh, B. P., Klopfleisch, R., Loh, G., Blaut, M.: Commensal Akkermansia muciniphila exacerbates gut inflammation in Salmonella typhimurium-infected gnotobiotic mice. PLoS ONE 8(9):e74963 (2013).

Hanske, L., Engst, W., Loh, G., Sczesny, S., Blaut, M., Braune, A.: Contribution of gut bacteria to the metabolism of cyanidin 3-glucoside in human microbiota-associated rats. Br. J. Nutr. 109, 1433-1441 (2013).

Kläring, K., Hanske, L., Bui, N., Charrier, C., Blaut, M., Haller, D., Plugge, C. M., Clavel, T. : Intestinimonas butyriciproducens gen. nov., sp. nov., a butyrate-producing bacterium from the mouse intestine. Int. J. Syst. Evol. Microbiol. 63, 4606-4612 (2013).

Rothe, M., Alpert, C., Loh, G., Blaut, M.: Novel insights into E. coli´s hexuronate metabolism: Kdul facilitates the conversion of galacturonate and glucuronate under osmotic stress conditions. PLoS ONE 8(2):e56906 (2013).

Rothe, M., Blaut, M.: Evolution of the gut microbiota and the influence of diet. Benef. Microbes 4, 31-37 (2013).

Schröder, C., Matthies, A., Engst, W., Blaut, M., Braune, A.: Identification and expression of genes involved in the conversion of daidzein and genistein by the equol-forming bacterium Slackia isoflavoniconvertens. Appl. Environ. Microbiol. 79, 3494-3502 (2013).

Slezak, K., Hanske, L., Loh, G., Blaut, M.: Increased bacterial putrescine has no impact on gut morphology and physiology in gnotobiotic adolescent mice. Benef. Microbes 4, 253-266 (2013).

Braune, A., Blaut, M.: Intestinal bacterium Eubacterium cellulosolvens deglycosylates flavonoid C- and O-Glucosides. Appl. Environ. Microbiol. 78, 8151-8153 (2012).

Ganesh, B. P., Richter, J. F., Blaut, M., Loh, G.: Enterococcus faecium NCIMB 10415 does not protect interleukin-10 knock-out mice from chronic gut inflammation. Benef. Microbes 3, 43-50 (2012).

Junick, J., Blaut, M.: Quantification of human fecal Bifidobacterium species by use of quantitative real-time PCR analysis targeting the groEL gene. Appl. Environ. Microbiol. 78, 2613-2622 (2012).

Loh, G., Blaut, M.: Role of commensal gut bacteria in inflammatory bowel diseaes. Gut Microbes 3, 544-555 (2012).

Mabrok, H. B., Klopfleisch, R., Ghanem, K. Z., Clavel, T., Blaut, M., Loh, G.: Lignan transformation by gut bacteria lowers tumor burden in a gnotobiotic rat model of breast cancer. Carcinogenesis 33, 203-208 (2012).

Matthies, A., Loh, G., Blaut, M., Braune, A.: Daidzein and genistein are converted to equol and 5-hydroxy-equol by human intestinal Slackia isoflavoniconvertens in gnotobiotic rats. J. Nutr. 142, 40-46 (2012).

Pfeiffer, N., Desmarchelier, C., Blaut, M., Daniel, H., Haller, D., Clavel, T.: Acetatifactor muris gen. nov., sp. nov., a novel bacterium isolated from the intestine of an obese mouse. Arch. Microbiol. 194, 901-907 (2012).

Rothe, M., Alpert, C., Engst, W., Musiol, S., Loh, G., Blaut, M.: Impact of nutritional factors on the proteome of intestinal Escherichia coli: Induction of OxyR-dependent proteins AhpF and Dps by a lactose-rich diet. Appl. Environ. Microbiol. 78, 3580-3591 (2012).

Schumann, S., Alpert, C. A., Engst, W., Loh, G., Blaut, M.: Dextran sodium sulfate-induced inflammation alters the expression of proteins by intestinal Escherichia coli strains in a gnotobiotic mouse model. Appl. Environ. Microbiol 78, 1513-1522 (2012).

Becker, N., Kunath, J., Loh, G., Blaut, M.: Human intestinal microbiota: Characterization of a simplified and stable gnotobiotic rat model. Gut Microbes 2, 25-33 Open Access (2011).

Braune, A., Blaut, M.: Deglycosylation of puerarin and other aromatic C-glucosides by a newly isolated human intestinal bacterium. Environ. Microbiol. 13, 482-494 (2011).

Henderson, G., Ulsemer, P., Schöber, U., Löffler, A., Alpert, C.-A., Zimmermann-Kordmann, M., Reutter, W., Karsten, U., Goletz, S., Blaut, M.: Occurence of the human tumour-specific antigen structure Galβ1-3GalNAcα-(Thomsen-Friedenreich) and related structures on gut bacteria: Prevalence immunochemical analysis and structural confirmation. Glycobiology 21, 1277-1289 (2011).

Kutschera, M., Engst, W., Blaut, M., Braune, A.: Isolation of catechin-converting human intestinal bacteria. J. Appl. Microbiol. 111, 165-175 (2011).

Weickert, M. O., Arafat, A. M., Blaut, M., Alpert, C., Becker, N., Leupelt, V., Rudovich, N., Moehlig, M., Pfeiffer, A. F. H.: Changes in dominant groups of the gut microbiota do not explain cereal‑fiber induced improvement of whole‑body insulin sensitivity. Nutr. Metab. 8:90 (Open Access) (2011).

Weickert, M. O., Roden, M., Isken, F., Hoffmann, D., Nowotny, P., Osterhoff, M., Blaut, M., Alpert, C., Gögebakan, Ö., Bumke-Vogt, C., Mueller, F., Machann, J., Barber, T. M., Petzke, K. J., Hierholzer, J., Hornemann, S., Kruse, M., Illner, A.-K., Kohl, A., Loeffelholz, C. V., Arafat, A. M., Möhlig, M., Pfeiffer, A. F. H.: Effects of supplemented isoenergetic diets differing in cereal fiber and protein content on insulin sensitivity in overweight humans. Am. J. Clin. Nutr. 94, 459-471 (2011).

Wohlgemuth, S., Keller, S., Kertscher, R., Stadion, M., Haller, D., Kisling, S., Jahreis, G., Blaut, M., Loh, G.: Intestinal steroid profiles and microbiota composition in colitic mice. Gut Microbes 2, 159-166 (2011).

Blaut, M., Bischoff, S. C.: Probiotics and Obesity. Ann. Nutr. Metab. 57 (Suppl. 1), 20-23 (2010).

Braune, A., Maul, R., Schebb, N. H., Kulling, S. E., Blaut, M.: The red clover isoflavone irilone is largely resistant to degradation by the human gut microbiota. Mol. Nutr. Food Res. 54, 929-938 (2010).

Fleissner, C., Huebel, N., Abd El-Bary, M. M., Loh, G., Klaus, S., Blaut, M.: Absence of intestinal microbiota does not protect mice from diet-induced obesity. Br. J. Nutr. 104, 919-929 (2010).

Hanske, L., Loh, G., Sczesny, S., Blaut, M., Braune, A.: Recovery and metabolism of xanthohumol in germ-free and human microbiota-associated rats. Mol. Nutr. Food Res. 54, 1405-1413 (2010).

Vogel-Scheel, J., Alpert, C., Engst, W., Loh, G., Blaut, M.: Requirement of purine and pyrimidine synthesis for colonization of the mouse intestine by Escherichia coli. Appl. Environ. Microbiol. 76, 5181-5187 (2010).

Wohlgemuth, S., Loh, G., Blaut, M.: Recent developments and perspectives in the investigation of probiotic effects. Int. J. Med. Microbiol. 300, 3-10 (2010).

Woting, A., Clavel, T., Loh, G., Blaut, M.: Bacterial transformation of dietary lignans in gnotobiotic rats. FEMS Microbiol. Ecol. 72, 507-514 (2010).

Alpert, C., Scheel, J., Engst, W., Loh, G., Blaut, M.: Adaption of protein expression by Escherichia coli in the gastrointestinal tract of gnotobiotic mice. Environ. Microbiol. 11, 751-761 (2009).

Braune, A., Bunzel, M., Yonekura, R., Blaut, M.: Conversion of dehydrodiferulic acids by human intestinal microbiota. J. Agric. Food Chem. 57, 3356-3362 (2009).

Hanske, L., Loh, G., Sczesny, S., Blaut, M., Braune, A.: The bioavailability of apigenin-7-glucoside is influenced by human intestinal microbiota in rats. J. Nutr. 139, 1095-1102 (2009).

Hrdina, J., Banning, A., Kipp, A., Loh, G., Blaut, M., Brigelius-Flohé, R.: The gastrointestinal microbiota affects the selenium status and selenoprotein expression in mice. J. Nutr. Biochem. 20, 638-648 (2009).

Matthies, A., Blaut, M., Braune, A: Isolation of a human intestinal bacterium capable of daidzein and genistein conversion. Appl. Environ. Microbiol. 75, 1740-1744 (2009).

Meinl, W., Sczesny, S., Brigelius-Flohé, R., Blaut, M., Glatt, H.: Impact of gut microbiota on intestinal and hepatic levels of phase 2 xenobiotic-metabolizing enzymes in the rat. Drug Metab. Dispos. 37, 1179-1186 (2009).

Reichardt, N., Gniechwitz, D., Steinhart, H., Bunzel, M., Blaut, M.: Characterization of high molecular weight coffee fractions and their fermentation by human intestinal microbiota. Mol. Nutr. Food Res. 53, 287-299 (2009).

Wohlgemuth, S., Haller, D., Blaut, M., Loh, G.: Reduced microbial diversity and high numbers of one single Escherichia coli strain in the intestine of colitic mice. Environ. Microbiol. 11, 1562-1571 (2009).

Alpert, C., Sczesny,S., Gruhl, B., Blaut, M.: Long-term stability of the human gut microbiota in two different rat strains. Curr. Issues Mol. Biol. 10, 17-24 (Open Access) (2008).

Loh, G., Brodziak, F., Blaut, M.: The toll-like receptors TLR2 and TLR4 do not affect the intestinal microbiota composition in mice. Environ. Microbiol. 10, 709-715 (2008).

Matthies, A., Clavel, T., Gütschow, M., Engst, W., Haller, D., Blaut, M., Braune, A. : Conversion of daidzein and genistein by an anaerobic bacterium newly isolated from the mouse intestine. Appl. Environ. Microbiol. 74, 4847-4852 (2008).

Mohan, R., Koebnick, C., Schildt, J., Mueller, M., Radke, M., Blaut, M.: Effects of Bifidobacterium lactis Bb12 supplementation on body weight, fecal pH, acetate, lactate, calprotectin and IgA in preterm infants. Pediatr. Res. 64, 418-422 (2008).

Blaut, M., Clavel, T.: Metabolic diversity of the intestinal microbiota: implications for health and disease. J. Nutr. 137, 751S-755S (2007).

Clavel, T., Lippman, R., Gavini, F., Doré, J., Blaut, M.: Clostridium saccharogumia sp. nov. and Lactonifactor longoviformis gen. nov., sp. nov., two novel human faecal bacteria involved in the conversion of the dietary phytoestrogen secoisolariciresinol diglucoside. Syst. Appl. Microbiol. 30, 16-26 (2007).

Namsolleck, P., Mohan, R., Koebnick, C., Blaut, M.: Centrifugation of bacterial cells on slide surface improves the spatial distribution, cell recovery and reduces the time of enumeration for fluorescence in situ hybridization. J. Microsc. 227, 8-14 (2007).

Blaut, M.: Molecular characterization and benefits of the intestinal ecosystem. Bioscience Microflora 25, 67-79 (2006).

Blaut, M., Braune, A., Wunderlich, S., Sauer, P., Schneider, H., Glatt, H.: Mutagenicity of arbutin in mammalian cells after activation by human intestinal bacteria. Food Chem. Toxicol. 44, 1940-1947 (2006).

Blaut, M., Marteau, P., Miller, G. D., Antoine, J.-M.: Probiotics and the intestinal microflora: what impact on the immune system, infections and aging?. Curr. Nutr. Food Sci. 2, 79-95 (2006).

Clavel, T., Borrmann, D., Braune, A., Dore, J., Blaut, M.: Occurrence and activity of human intestinal bacteria involved in the conversion of dietary lignans. Anaerobe 12, 140-147 (2006).

Clavel, T., Doré, J., Blaut, M.: Bioavailability of lignans in human subjects. Nutr. Res. Rev. 19, 187-196 (2006).

Clavel, T., Henderson, G., Engst, W., Doré, J., Blaut, M.: Phylogeny of human intestinal bacteria that activate the dietary lignan secoisolariciresinol diglucoside. FEMS Microbiol. Ecol. 55, 471-478 (2006).

Hanske, L., Blaut, M.: Wirkmechanismen von Probiotika. Aktuel. Ernaehr. Med. 31, 317-321 (2006).

Kroesen, A. J., Leistenschneider, P., Lehmann, K., Ransco, C., Dullat, S., Blaut, M., Schulzke, J. D., Fromm, M., Buhr, H. J.: Increased bacterial permeation in long-lasting ileoanal pouches. Inflamm. Bowel Dis. 12, 736-744 (2006).

Mohan, R., Koebnick, C., Schildt, J., Schmidt, S., Mueller, M., Possner, M., Radke, M., Blaut, M.: Effects of Bifidobacterium lactis Bb12 supplementation on intestinal microbiota of preterm infants: a double-blind, placebo-controlled, randomized study. J. Clin. Microbiol. 44, 4025-4031 (2006).

Mohan, R., Namsolleck, P., Lawson, P. A., Osterhoff, M., Collins, M. D., Alpert, C.-A., Blaut, M.: Clostridium asparagiforme sp. nov., isolated from a human faecal sample. Syst. Appl. Microbiol. 29, 292-299 (2006).

Mueller, S., Saunier, K., Hanisch, C., Norin, E., Alm, L., Midtvedt, T., Cresci, A., Silvi, S., Orpianesi, C., Verdenelli, M. C., Clavel, T., Koebnick, C., Zunft, H.-J. F., Doré, J., Blaut, M. : Differences in fecal microbiota in different European study populations in relation to age, gender, and country: a cross-sectional study. Appl. Environ. Microbiol. 72, 1027-1033 (2006).

Alpert, C., Engst, W., Guehler, A., Oelschlaeger, T., Blaut, M.: Bacterial response to eukaryotic cells. Analysis of differentially expressed proteins using nano liquid chromatography-electrospray ionization tandem mass spectrometry. J. Chromatogr. A 1082, 25-32 (2005).

Braune, A., Engst, W., Blaut, M.: Degradation of neohesperidin dihydrochalcone by human intestinal bacteria. J. Agric. Food Chem. 53, 1782-1790 (2005).

Clavel, T., Fallani, M., Lepage, P., Levenez, F., Mathey, J., Rochet, V., Sérézat, M., Sutren, M., Henderson, G., Bennetau-Pelissero, C., Tondu, F., Blaut, M., Doré, J., Coxam, V.: Isoflavones and functional foods alter the dominant intestinal microbiota in postmenopausal women. J. Nutr. 135, 2786-2792 (2005).

Clavel, T., Henderson, G., Alpert, C.-A., Philippe, C., Rigottier-Gois, L., Doré, J., Blaut, M.: Intestinal bacterial communities that produce the active estrogen-like compounds enterodiol and enterolactone in humans. Appl. Environ. Microbiol. 71, 6077-6085 (2005).

Hanske, L., Hussong, R., Frank, N., Gerhäuser, C., Blaut, M., Braune, A.: Xanthohumol does not affect the composition of rat intestinal microbiota. Mol. Nutr. Food Res. 49, 868-873 (2005).

Kleessen, B., Blaut, M.: Modulation of gut mucosal biofilms. Br. J. Nutr. 93 (Suppl. 1), S35-S40 (2005).

Thiel, R., Blaut, M.: An improved method for the automated enumaration of fluorescently labelled bacteria in human faeces. J. Microbiol. Methods 61, 369-379 (2005).

Weickert, M. O., Mohlig, M., Koebnick, C., Holst, J. J., Namsolleck, P., Ristow, M., Osterhoff, M., Rochlitz, H., Rudovich, N., Spranger, J., Pfeiffer, A. F. H. : Impact of cereal fibre on glucose-regulating factors. Diabetologia 48, 2343-2353 (2005).

Akkar, A., Namsolleck, P., Blaut, M., Müller, R. H.: Solubilizing poorly soluble antimycotic agents by emulsification via a solvent-free process. AAPS Pharm. Sci. Tech. 5 (1), Article 24 (Open Access) (2004).

Herles, C., Braune, A., Blaut, M.: First bacterial chalcone isomerase isolated from Eubacterium ramulus. Arch. Microbiol. 181, 428-434 (2004).

Schoefer, L., Braune, A., Blaut, M.: Cloning and expression of a phloretin hydrolase gene from Eubacterium ramulus and characterization of the recombinat enzyme. Appl. Environ. Microbiol. 70, 6131-6137 (2004).

Blaut, M., Schoefer, L., Braune, A.: Transformation of flavonoids by intestinal microorganisms. Int. J. Vitam. Nutr. Res. 73, 79-87 (2003).

Hold, G. L., Schwiertz, A., Aminov, R. I., Blaut, M., Flint, H. J.: Oligonucleotide probes that detect quantitatively significant groups of butyrate-producing bacteria in human feces. Appl. Environ. Microbiol. 69, 4320-4324 (2003).

Kharazmi, M., Sczesny, S., Blaut, M., Hammes, W. P., Hertel, C.: Marker rescue studies of the transfer of recombinant DNA to streptococcus gordonii in vitro, in foods and gnotobiotic rats. Appl. Environ. Microbiol. 69, 6121-6127 (2003).

Kleessen, B., Hartmann, L., Blaut, M.: Fructans in the diet cause alterations of intestinal mucosal architecture, released mucins and mucosa-associated bifidobacteria in gnotobiotic rats. Br. J. Nutr. 89, 597-606 (2003).

Schoefer, L., Mohan, R., Schwiertz, A., Braune, A., Blaut, M.: Anaerobic degradation of flavonoids by Clostridium orbiscindens. Appl. Environ. Microbiol. 69, 5849-5854 (2003).

Schwiertz, A., Gruhl, B., Löbnitz, M., Michel, P., Radke, M., Blaut, M.: Development of the intestinal bacterial composition in hospitalized preterm infants in comparison with breast-fed, full-term infants. Pediatr. Res. 54, 393-399 (2003).

Herles, C., Braune, A., Blaut, M.: Purification and characterization of an NADH oxidase from Eubacterium ramulus. Arch. Microbiol. 178, 71-74 (2002).

Kleessen, B., Kroesen, A. J., Buhr, H. J., Blaut, M.: Mucosal and invading bacteria in patients with inflammatory bowel disease compared with controls. Scand. J. Gastroenterol. 37, 1034-1041 (2002).

Schoefer, L., Mohan, R., Braune, A., Birringer, M., Blaut, M.: Anaerobic C-ring cleavage of genistein and daidzein by Eubacterium ramulus. FEMS Microbiol. Lett. 208, 197-202 (2002).

Schwiertz, A., Hold, G. L., Duncan, S. H., Gruhl, B., Collins, M. D., Lawson, P. A., Flint, H. J., Blaut, M.: Anaerostipes caccae gen. nov., sp. nov., a new saccharolytic, acetate-utilising, butyrate-producing bacterium from human faeces. Syst. Appl. Microbiol. 25, 46-51 (2002).

Schwiertz, A., Lehmann, U., Jacobasch, G., Blaut, M.: Influence of resistant starch on the SCFA production and cell counts of butyrate-producing Eubacterium spp. in the human intestine. J. Appl. Microbiol. 93, 157-162 (2002).

Simmering, R., Pforte, H., Jacobasch, G., Blaut, M.: The growth of the flavonoid-degrading intestinal bacterium, Eubacterium ramulus, is stimulated by dietary flavonoids in vivo. FEMS Microbiol. Ecol. 40, 243-248 (2002).

Simmering, R., Taras, D., Schwiertz, A., Le Blay, G., Gruhl, B., Lawson, P. A., Collins, M. D., Blaut, M.: Ruminococcus luti sp. nov, isolated from a human faecal sample. Syst. Appl. Microbiol. 25, 189-193 (2002).

Taras, D., Simmering, R., Collins, M. D., Lawson, P. A., Blaut, M.: Reclassification of Eubacterium formicigenerans Holdeman and Moore 1974 as Dorea formicigenerans gen. nov., comb. nov., and description of Dorea longicatena sp. nov., isolated from human faeces. Int. J. Syst. Evol. Microbiol. 52, 423-428 (2002).

Braune, A., Gutschow, M., Engst, W., Blaut, M.: Degradation of quercetin and luteolin by Eubacterium ramulus. Appl. Environ. Microbiol. 67, 5558-5567 (2001).

Hammer, E., Schoefer, L., Schäfer, A., Hundt, K., Schauer, F.: Formation of glucoside conjugates during biotransformation of dibenzofuran by Penicillium canescens SBUG-M 1139. Appl. Microbiol. Biotechnol. 57, 390-394 (2001).

Kleessen, B., Hartmann, L., Blaut, M.: Oligofructose and long-chain inulin: influence on the gut microbial ecology of rats associated with a human faecal flora. Br. J. Nutr. 86, 291-300 (2001).

Schoefer, L., Braune, A., Blaut, M.: A fluorescence quenching test for the detection of flavonoid transformation. FEMS Microbiol. Lett. 204, 277-280 (2001).

Wiesener, M. S., Munchenhagen, P. M., Berger, I., Morgan, N. V., Roigas, J., Schwiertz, A., Jurgensen, J. S., Gruber, G., Maxwell, P. H., Loning, S. A., Frei, U., Maher, E. R., Grone, H. J., Eckardt, K. U.: Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1alpha in clear cell renal carcinomas. Cancer Res. 61, 5215-5222 (2001).

Dongowski, G., Lorenz, A., Anger, H.: Degradation of pectins with different degrees of esterification by Bacteroides thetaiotaomicron isolated from human gut flora. Appl. Environ. Microbiol. 66, 1321-1327 (2000).

Hartmann, L., Taras, D., Kamlage, B., Blaut, M.: A new technique to determine hydrogen excreted by gnotobiotic rats. Lab. Anim. 34, 162-170 (2000).

Kamlage, B., Hartmann, L., Gruhl, B., Blaut, M.: Linoleic acid conjugation by human intestinal microorganisms is inhibited by glucose and other substances in vitro and in gnotobiotic rats. J. Nutr. 130, 2036-2039 (2000).

Noack, J., Dongowski, G., Hartmann, L., Blaut, M.: The human gut bacteria Bacteroides thetaiotaomicron and Fusobacterium varium produce putrescine and spermidine in cecum of pectin-fed gnotobiotic rats. J. Nutr. 130, 1225-1231 (2000).

Scharek, L., Hartmann, L., Heinevetter, L., Blaut, M.: Bifidobacterium adolescentis modulates the specific immune response to another human gut bacterium Bacteroides thetaiotaomicron, in gnotobiotic rats. Immunobiology 202, 429-441 (2000).

Schneider, H., Blaut, M.: Anaerobic degradation of flavonoids by Eubacterium ramulus. Arch. Microbiol. 173, 71-75 (2000).

Schneider, H., Simmering, R., Hartmann, L., Pforte, H., Blaut, M.: Degradation of quercetin-3-glucoside in gnotobiotic rats associated with human intestinal bacteria. J. Appl. Microbiol. 89, 1027-1037 (2000).

Schwiertz, A., Le Blay, G., Blaut, M.: Quantification of different Eubacterium spp. in human fecal samples with species-specific 16S rRNA-targeted oligonucleotide probes. Appl. Environ. Microbiol. 66, 375-382 (2000).

Original Papers (corresponding author other than DIfE)

Alhasan, M. M., Cait, A. M., Heimesaat, M. M., Blaut, M., Klopfleisch, R., Wedel, A., Conlon, T. M., Yildirim, A. O., Sodemann, E. B., Mohn, W. W., Bereswill, S., Conrad, M. L.: Antibiotic use during pregnancy increases offspring asthma severity in a dose dependent manner. Allergy in press (E-pub ahead of print) (2020).

Ocvirk, S., Wilson, A. S., Posma, J. M., Li, J. V., Koller, K. R., Day, G. M., Flanagan, C. A., Otto, J. E., Sacco, P. E., Sacco, F. D., Sapp, F. R., Wilson, A. S., Newton, K., Brouard, F., DeLany, J. P., Behnning, M., Appolonia, C. N., Soni, D., Bhatti, F., Methe, B., Fitch, A., Morris, A., Gaskins, H. R., Kinross, J., Nicholson, J. K., Thomas, T. K., O’Keefe, S. J. D.: A prospective cohort analysis of gut microbial co-metabolism in Alaska Native and rural African people at high and low risk of colorectal cancer. Am J Clin Nutr 111(2), 406–419 (2020).

Simon, M. C., Reinbeck, A. L., Wessel, C., Heindirk, J., Jelenik, T., Kaul, K., Arreguin-Cano, J., Strom, A., Blaut, M., Backhed, F., Burkart, V., Roden, M.: Distinct alterations of gut morphology and microbiota characterize accelerated diabetes onset in non-obese diabetic mice. J Biol Chem 295, 969-980 (2020).

Katsidzira, L., Ocvirk, S., Wilson, A., Li, J., Mahachi, C. B., Soni, D., DeLany, J., Nicholson, J. K., Zoetendal, E. G., O’Keefe, S. J. D.: Differences in fecal gut microbiota, short-chain fatty acids and bile acids link colorectal cancer risk to dietary changes associated with urbanization among Zimbabweans. Nutr. Cancer. 71, 1313-1324 (2019).

Schmidt, F., Dahlke, K., Batra, A., Keye, J., Wu, H., Friedrich, M., Glauben, R., Ring, C., Loh, G., Schaubeck, M., Hackl, H., Trajanoski, Z., Schumann, M., Kühl, A. A., Blaut, M., Siegmund, B.: Microbial colonization in adulthood shapes the intestinal macrophage compartment. J. Crohns Colitis 13, 1173-1185 (2019).

Schuchardt, M., Prüfer, N., Tu, Y., Herrmann, J., Hu, X. P., Chebli, S., Dahlke, K., Zidek, W., van der Giet, M., Tölle, M.: Dysfunctional high-density lipoprotein activates toll-like receptors via serum amyloid A in vascular smooth muscle cells. Sci. Rep. 9(1):3421 (2019).

Lino, A. C., Dang, V. D., Lampropoulou, V., Welle, A., Joedicke, J., Pohar, J., Simon, Q., Thalmensi, J., Baures, A., Flühler, V., Sakwa, I., Stervbo, U., Ries, S., Jouneau, L., Boudinot, P., Tsubata, T., Adachi, T., Hutloff, A., Dörner, T., Zimber-Strobl, U., de Vos, A. F., Dahlke, K., Loh, G., Korniotis, S., Goosmann, C., Weill, J. C., Reynaud, C. A., Kaufmann, S. H. E., Walter, J., Fillatreau, S.: LAG-3 inhibitory receptor expression identifies immunosuppressive natural regulatory plasma cells. Immunity 49, 120-133 (2018).

Schulz-Fincke, A.-C., Tikhomirov, A. S., Braune, A., Girbl, T., Gilberg, E., Bajorath, J., Blaut, M., Nourshargh, S., Gütschow, M.: Design of an activity-based probe for human neutrophil elastase: implementation of the lossen rearrangement to induce Förster Resonance Energy Transfers. Biochemistry 57, 742-752 (2018).

Costea, P. I., Zeller, G., Sunagawa, S., Pelletier, E., Alberti, A., Levenez, F., Tramontano, M., Driessen, M., Hercog, R., Jung, F. E., Kultima, J. R., Hayward, M. R., Coelho, L. P., Allen-Vercoe, E., Bertrand, L., Blaut, M., Brown, J. R. M., Carton, T., Cools-Portier, S., Daigneault, M., Derrien, M., Druesne, A., de Vos, W. M., Finlay, B. B., Flint, H. J., Guarner, F., Hattori, M., Heilig, H., Luna, R. A., van Hylckama Vlieg, J., Junick, J., Klymiuk, I., Langella, P., Le Chatelier, E., Mai, V., Manichanh, C., Martin, J. C., Mery, C., Morita, H., O’Toole, P. W., Orvain, C., Patil, K. R., Penders, J., Persson, S., Pons, N., Popova, M., Salonen, A., Saulnier, D., Scott, K. P., Singh, B., Slezak, K., Veiga, P., Versalovic, J., Zhao, L., Zoetendal, E. G., Ehrlich, S. D., Dore, J., Bork, P.: Towards standards for human fecal sample processing in metagenomic studies. Nat. Biotechnol. 35, 1069-1076 (2017).

Lassenius, M. I., Fogarty, C. L., Blaut, M., Haimila, K., Riittinen, L., Paju, A., Kirveskari, J., Järvelä, J., Ahola, A. J., Gordin, D., Härma, M. A., Kumar, A., Hamarneh, S. R., Hodin, R. A., Sorsa, T., Tervahartiala, T., Hörkkö, S., Pussinen, P. J., Forsblom, C., Jauhiainen, M., Taskinen, M. R., Groop, P. H., Lehto, M.; FinnDiane Study Group: Intestinal alkaline phosphatase at the crossroad of intestinal health and disease - a putative role in type 1 diabetes. J. Intern. Med. 281, 586-600 (2017).

Benedict, C., Vogel, H., Jonas, W., Woting, A., Blaut, M., Schürmann, A., Cedernaes, J.: Gut microbiota and glucometabolic alterations in response to recurrent partial sleep deprivation in normal-weight young individuals. Mol. Metab. 5, 1175-1186 (2016).

Clavel, T., Lagkouvardos, I., Blaut, M., Stecher, B.: The mouse gut microbiome revisited: From complex diversity to model ecosystems. Int. J. Med. Microbiol. 306, 316-327 (2016).

Gabr, A. M. M., Mabrok, H. B., Ghanem, K. Z., Blaut, M., Smetanska, I.: Lignan accumulation in callus and Agrobacterium rhizogenes-mediated hairy root cultures of flax (Linum usitatissimum). Plant Cell Tiss. Organ Cult. 126, 255-267 (2016).

Häußler, D., Mangold, M., Furtmann, N., Braune, A., Blaut, M., Bajorath, J., Stirnberg, M., Gütschow, M.: Phosphono bisbenzguanidines as irreversible dipeptidomimetic inhibitors and activity-based probes of matriptase-2. Chemistry 22, 8525-8535 (2016).

Rausch, P., Basic, M., Batra, A., Bischoff, S. C., Blaut, M., Clavel, T., Gläsner, J., Gopalakrishnan, S., Grassl, G. A., Günther, C., Haller, D., Hirose, M., Ibrahim, S., Loh, G., Mattner, J., Nagel, S., Pabst, O., Schmidt, F., Siegmund, B., Strowig, T., Volynets, V., Wirtz, S., Zeissig, S., Zeissig, Y., Bleich, A., Baines, J. F.: Analysis of factors contributing to variation in the C57BL/6J fecal microbiota across German animal facilities. Int. J. Med. Microbiol. 306, 343-355 (2016).

Simeoni, U., Berger, B., Junick, J., Blaut, M., Pecquet, S., Rezzonico, E., Grathwohl, D., Sprenger, N., Brüssow, H; Study team, Szajewska H.: Gut microbiota analysis reveals a marked shift to bifidobacteria by a starter infant formula containing a synbiotic of bovine milk-derived oligosaccharides and Bifidobacterium animalis subsp. lactis CNCM I-3446. Environ. Microbiol. 18, 2185-2195 (Open Access) (2016).

Platz, S., Piberger, A. L., Budnowski, J., Herz, C., Schreiner, M., Blaut, M., Hartwig, A., Lamy, E., Hanske, L., Rohn, S.: Bioavailability and biotransformation of sulforaphane and erucin metabolites in different biological matrices determined by LC-MS-MS. Anal. Bioanal. Chem. 407, 1819-1829 (2015).

Quince, C., Ijaz, U. Z., Loman, N., Eren, A. M., Saulnier, D., Russell, J., Haig, S. J., Calus, S. T., Quick, J., Barclay, A., Bertz, M., Blaut, M., Hansen, R., McGrogan, P., Russell, R. K., Edwards, C. A., Gerasimidis, K.: Extensive modulation of the fecal metagenome in children with Crohn’s disease during exclusive enteral nutrition. Am. J. Gastroenterol. 110, 1718-1729 (Open Access) (2015).

Ulbrich, K., Reichardt, N., Braune, A., Kroh, L. W., Blaut, M., Rohn, S.: The microbial degradation of onion flavonol glucosides and their roasting products by the human gut bacteria Eubacterium ramulus and Flavonifractor plautii. Food Res. Int. 67, 349–355 (2015).

Daniel, H., Gholami, A. M., Berry, D., Desmarchelier, C., Hahne, H., Loh, G., Mondot, S., Lepage, P., Rothballer, M., Walker, A., Böhm, C., Wenning, M., Wagner, M., Blaut, M., Schmitt-Kopplin, P., Kuster, B., Haller, D., Clavel, T.: High-fat diet alters gut microbiota physiology in mice. ISME Journal 8, 295-308 (2014).

Gerasimidis, K., Bertz, M., Hanske, L., Junick, J., Biskou, O., Aguilera, M., Garrick, V., Russell, R. K., Blaut, M., McGrogan, P., Edwards, C. A.: Decline in presumptively protective gut bacterial species and metabolites are paradoxically associated with disease improvement in pediatric Crohn’s disease during enteral nutrition. Inflamm. Bowel Dis. 20, 861-871 (2014).

Schulz, M. D., Atay, C., Heringer, J., Romrig, F. K., Schwitalla, S., Aydin, B., Ziegler, P. K., Varga, J., Reindl, W., Pommerenke, C., Salinas-Riester, G., Böck, A., Alpert, C., Blaut, M., Polson, S. C., Brandl, L., Kirchner, T., Greten, F. R., Polson, S. W., Arkan, M. C.: High-fat-diet-mediated dysbiosis promotes intestinal carcinogenesis independently of obesity. Nature 514, 508-512 (2014).

Spinler, J. K., Sontakke, A., Hollister, E. B., Venable, S. F., Oh, P. L., Balderas, M. A., Saulnier, D. M., Mistretta, T. A., Devaraj, S., Walter, J., Versalovic, J., Highlander, S. K.: From prediction to function using evolutionary genomics: human-specific ecotypes of Lactobacillus reuteri have diverse probiotic functions. Genome Biol. Evol. 6, 1772-1789 (Open Access) (2014).

Ulsemer, P., Henderson, G., Toutounian, K., Löffler, A., Schmidt, J., Karsten, U., Blaut, M., Goletz, S.: Specific humoral immune response to the Thomsen-Friedenreich tumor antigen (CD176) in mice after vaccination with the commensal bacterium Bacteroides ovatus D-6. Cancer Immunol. Immunother. 62, 875-887 (2013).

Wuensch, T., Schulz, S., Ullrich, S., Lill, N., Stelzl, T., Rubio-Aliaga, I., Loh, G., Chamaillard, M., Haller, D., Daniel, H.: The peptide transporter PEPT1 is expressed in distal colon in rodents and humans and contributes to water absorption. Am. J. Physiol./Gastrointest. Liver Physiol. 305, G66-G73 (2013).

Patterson, A. M., Delday, M. I., van Kuppevelt, T. H., Loh, G., Blaut, M., Haller, D., Grant, G., Kelly, D.: Expression of heparan sulfate proteoglycans in murine models of experimental colitis. Inflamm. Bowel Dis. 18, 1112-1126 (2012).

von Schillde, M.-A., Hörmannsperger, G., Weiher, M., Alpert, C.-A., Hahne, H., Bäuerl, C., van Huynegem, K., Steidler, L., Hrncir, T., Pérez-Martínez, G., Kuster, B., Haller, D.: Lactocepin secreted by Lactobacillus exerts anti-inflammatory effects by selectively degrading proinflammatory chemokines. Cell Host Microbe 11, 387-396 (2012).

Elsinghorst, P. W., Cavlar, T., Müller, A., Braune, A., Blaut, M., Gütschow, M.: The termal and enzymatic taxifolin-alphitonin rearrangement. J. Nat. Prod. 74, 2243-2249 (2011).

Hörmannsperger, G., Clavel, T., Hoffmann, M., Reiff, C., Kelly, D., Loh, G., Blaut, M., Hölzlwimmer, G., Haller, D.: Posttranslational inhibition of proinflammatory chemokine secretion in intestinal epithelial cells: implications for specific IBD indications. J. Clin. Gastroenterol. 44, S10-S15 (2010).

Oozeer, R., Rescigno, M., Ross, R. P., Knol, J., Blaut, M., Khlebnikov, A., Doré, J.: Gut health: predictive biomarkers for preventive medicine and development of functional foods. Br. J. Nutr. 103, 1539-1544 (2010).

Chaillou, S., Daty, M., Baraige, F., Dudez, A.-M., Anglade, P., Jones, R., Alpert, C.-A., Champomier-Vergès, M.-C., Zagorec, M.: Intraspecies genomic diversity and natural population structure of the meat-borne lactic acid bacterium Lactobacillus sakei. Appl. Environ. Microbiol. 75, 970-980 (2009).

Clavel, T., Charrier, C., Braune, A., Wenning, M., Blaut, M., Haller, D.: Isolation of bacteria from the ileal mucosa of TNFdeltaARE mice and description of Enterorhabdus mucosicola gen. nov., sp. nov.. Int. J. Syst. Evol. Microbiol. 59, 1805-1812 (2009).

Hörmannsperger, G., Clavel, T., Hoffmann, M., Reiff, C., Kelly, D., Loh, G., Blaut, M., Hölzlwimmer, G., Laschinger, M., Haller, D.: Post-translational inhibition of IP-10 secretion in IEC by probiotic bacteria: impact on chronic inflammation. PLoS ONE 4(2), e4365 (Open Access) (2009).

Martin, F.-P., Rezzi, S., Montoliu, I., Philippe, D., Tornier, L., Messlik, A., Hölzlwimmer, G., Baur, P., Quintanilla-Fend, L., Loh, G., Blaut, M., Blum, S., Kochhar, S., Haller, D.: Metabolic assessment of gradual development of moderate experimental colitis in IL-10 deficient mice. J. Proteome Res. 8, 2376-2387 (2009).

Reiff, C., Delday, M., Rucklidge, G., Reid, M., Duncan, G., Wohlgemuth, S., Hörmannsperger, G., Loh, G., Blaut, M., Collie-Duguid, E., Haller, D., Kelly, D.: Balancing inflammatory, lipid, and xenobiotic signaling pathways by VSL#3, a biotherapeutic agent, in the treatment of inflammatory bowel disease. Inflamm. Bowel Dis. 15, 1721-1736 (2009).

Gniechwitz, D., Reichardt, N., Meiss, E., Ralph, J., Steinhart, H., Blaut, M., Bunzel, M.: Characterization and fermentability of an ethanol soluble high molecular weight coffee fraction. J. Agric. Food Chem. 56, 5960-5969 (2008).

Funk, C., Braune, A., Grabber, J. H., Steinhart, H., Bunzel, M.: Moderate ferulate and diferulate levels do not impede maize cell wall degradation by human intestinal microbiota. J. Agric. Food Chem. 55, 2418-2423 (2007).

Funk, C., Braune, A., Grabber, J. H., Steinhart, H., Bunzel, M.: Model studies of lignified fiber fermentation by human fecal microbiota and its impact on heterocyclic aromatic amine adsorption. Mutat. Res./Fund. Mol. Mech. Mutagen. 624, 41-48 (2007).

Gniechwitz, D., Brueckel, B., Reichardt, N., Blaut, M., Steinhart, H., Bunzel, M.: Coffee dietary fiber contents and structural characteristics as influenced by coffee type and technological and brewing procedures. J. Agric. Food Chem. 55, 11027-11034 (2007).

Gniechwitz, D., Reichardt, N., Blaut, M., Steinhart, H., Bunzel, M.: Dietary fiber from coffee beverage: degradation by human fecal microbiota. J. Agric. Food Chem. 55, 6989-6996 (2007).

Heimesaat, M. M., Fischer, A., Jahn, H.-K., Niebergall, J., Freudenberg, M., Blaut, M., Liesenfeld, O., Schumann, R. R., Göbel, U. B., Bereswill, S.: Exacerbation of murine ileitis by toll-like receptor 4 mediated sensing of lipopolysaccharide from commensal Escherichia coli. Gut 56, 941-948 (2007).

Heimesaat, M. M., Fischer, A., Siegmund, B., Kupz, A., Niebergall, J., Fuchs, D., Jahn, H.-K., Freudenberg, M., Loddenkemper, C., Batra, A., Lehr, H.-A., Liesenfeld, O., Blaut, M., Göbel, U. B., Schumann, R. R., Bereswill, S.: Shift towards pro-inflammatory intestinal bacteria aggravates acute murine colitis via toll-like receptors 2 and 4. PLoS ONE 2(7), e662 (Open Access) (2007).

Ruiz, P. A., Braune, A., Hölzlwimmer, G., Quintanilla-Fend, L., Haller, D.: Quercetin inhibits TNF-induced NF-κB transcription factor recruitment to proinflammatory gene promoters in murine intestinal epithelial cells. J. Nutr. 137, 1208-1215 (2007).

Gostner, A., Blaut, M., Schäffer, V., Kozianowski, G., Theis, S., Klingeberg, M., Dombrowski, Y., Martin, D., Ehrhardt, S., Taras, D., Schwiertz, A., Kleessen, B., Lührs, H., Schauber, J., Dorbath, D., Menzel, T., Scheppach, W.: Effects of isomalt consumption on faecal microflora and colonic metabolism in healthy volunteers. Br. J. Nutr. 95, 40-50 (2006).

Kühbacher, T., Ott, S. J., Helwig, U., Mimura, T., Rizzello, F., Kleessen, B., Gionchetti, P., Blaut, M., Campieri, M., Fölsch, U. R., Kamm, M. A., Schreiber, S.: Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis. Gut 55, 833-841 (2006).

Ott, S. J., El Mokhtari, N. E., Musfeldt, M., Hellmig, S., Freitag, S., Rehman, A., Kühbacher, T., Nikolaus, S., Namsolleck, P., Blaut, M., Hampe, J., Sahly, H., Reinecke, A., Haake, N., Günther, R., Krüger, D., Lins, M., Herrmann, G., Fölsch, U. R., Simon, R., Schreiber, S.: Detection of diverse bacterial signatures in atherosclerotic lesions of patients with coronary heart disease. Circulation 113, 929-937 (2006).

Lay, C., Rigottier-Gois, L., Holmstrøm, K., Rajilic, M., Vaughan, E. E., de Vos, W. M., Collins, M. D., Thiel, R., Namsolleck, P., Blaut, M., Doré, J.: Colonic microbiota signatures across five Northern European countries. Appl. Environ. Microbiol. 71, 4153-4155 (2005).

Ruiz, P. A., Hoffmann, M., Szcesny, S., Blaut, M., Haller, D.: Innate mechanisms for Bifidobacterium lactis to activate transient pro-inflammatory host responses in intestinal epithelial cells after the colonization of germ-free rats. Immunology 115, 441-450 (2005).


Trefflich, I., Jabakhanji, A., Menzel, J., Blaut, M., Michalsen, A., Lampen, A., Abraham, K., Weikert, C.: Is a vegan or a vegetarian diet associated with the microbiota composition in the gut? Results of a new cross-sectional study and systematic review. Crit Rev Food Sci Nutr in press (2020).

Wilson, A. S., Koller, K. R., Ramaboli, M. C., Nesengani, L. T., Ocvirk, S., Chen, C., Flanagan, C. A., Sapp, F. R., Merritt, Z. T., Bhatti, F., Thomas, T. K., O’Keefe, S. J. D.: Diet and the Human Gut Microbiome: An International Review. Dig Dis Sci 65(3), 723-740 (2020).

Ocvirk, S., Wilson, A. S., Appolonia, C. N., Thomas, T. K., O’Keefe, S. J. D.: Fiber, Fat, and Colorectal Cancer: New Insight into Modifiable Dietary Risk Factors. Curr Gastroenterol Rep 21(11):62 (2019).

Mandić, A. D., Blaut, M.: Do we choose control diets wisely?. Trends Endocrinol. Metab. 29, 447-448 (2018).

Blaut, M.: Intestinal microbiome fundamentals and influence of diet. Diabetologe 12, 386-393 (2016).

Blaut, M.: Regulation of the microbiome by diet. Diabetologe 12, 394-400 (2016).

Braune, A. Blaut, M.: Bacterial species involved in the conversion of dietary flavonoids in the human gut. Gut Microbes 7, 216-234 (2016).

Woting, A., Blaut, M.: The intestinal microbiota in metabolic disease. Nutrients 8, 202 (Open Access) (2016).

Blaut, M.: Interaktion von Ballaststoffen und Mikrobiota [Interaction of Dietary Fiber and Microbiota]. Aktuel. Ernaehr. Med. 40, 43-49 (2015).

Blaut, M.: Gut microbiota and energy balance: role in obesity. Proc. Nutr. Soc. 74, 227-234 (2015).

Blaut, M.: Ernährungsabhängige Einflüsse der intestinalen Mikrobiota [Nutrition-mediated Effects of the intestinal Microbiota]. Ernaehr. Umsch. 62, 216-229 (2015).

Blaut, M.: Ecology and physiology of the intestinal tract. Curr. Top. Microbiol. Immunol. 358, 247-272 (2013).

Blaut, M.: Vielfalt der Kulturen. Zusammensetzung und Funktion der Mikrobiota im Darm. Aktuel. Ernaehr. Med. 37(S1), S2-S6 (2012).

Blaut, M., Klaus, S.: Intestinal microbiota and obesity. In: Joost, H.-G. (ed.) Appetite Control (Handbook of Experimental Pharmacology, Vol. 209), Springer, Berlin Heidelberg, pp 251-273 (2012).

Blaut, M.: Wirkung steigern oder schwächen? Chemische Umwandlung sekundärer Pflanzenstoffe durch Darmbakterien und deren physiologische Bedeutung. Aktuel. Ernaehr. Med. 36, S29-S32 (2011).

Namsolleck, P., Thiel, R., Lawson, P., Holmstrøm, K., Rajilic, M., Vaughan, E. E., Rigottier-Gois, L., Collins, M. D., de Vos, W. M., Blaut, M.: Molecular methods for the analysis of gut microbiota. Microbial Ecol. Health Dis. 16, 71-85 (2004).

Blaut, M.: Relationship of prebiotics and food to intestinal microflora. Eur. J. Nutr. 41, Suppl.1, I/11-I/16 (2002).

Blaut, M., Collins, M. D., Welling, G. W., Doré, J., van Loo, J., de Vos, W.: Molecular biological methods for studying the gut microbiota: the EU human gut flora project. Br. J. Nutr. 87, Suppl. 2, S203-S211 (2002).

Mattila-Sandholm, T., Blaut, M., Daly, C., De Vuyst, L., Doré, J., Gibson, G., Goossens, H., Knorr, D., Lucas, J., Lähteenmaki, L., Mercenier, A., Saarela, M., Shanahan, F., de Vos, W. M.: Food, GI-tract functionality and human health cluster: PROEUHEALTH. Microbial Ecol. Health Dis. 14, 65-74 (2002).

Simmering, R., Blaut, M.: Pro- and prebiotics - the tasty guardian angels?. Appl. Microbiol. Biotechnol. 55, 19-28 (2001).

Book Articles

Alhasan, M., Cait, A., Heimesaat, M., Blaut, M., Klopfleisch, R., Conlon, T. M., Yildirim, A., Sodemann, E. B., Bereswill, S., Conrad, M.: Administering antibiotics during pregnancy increases offspring asthma severity in a dose-dependent manner. Pneumologie 74(S 01): 73 (2020).

Blaut, M.: Role of intestinal bacteria in gut inflammation and obesity. In: Heldt, P. J., Versalovic, J., Schwiertz, A., Rusch, V. (eds.) Microbial metabolism and mammalian physiology: one integrated system (Old Herborn University Seminar Monograph; 29), pp. 51-62 (2015).

Saulnier, D. M., Blaut, M.: Prebiotics Beyond Fibers. In: Venema, K., do Carmo, A. P. (eds.) Probiotics and Prebiotics: Current Research and Future Trends. Caister Academic Press, pp. 331-334 (2015).

Blaut, M.: Die wichtige Rolle der mikrobiellen Lebensgemeinschaft im Darm. In: Schärer-Züblin, E. V. (Hrsg.) Forschung und Ernährung - ein Dialog. Alimentarium, Wiley-Blackwell, Weinheim, 2009, S. 116-124 (2009).

Blaut, M., Collins, M. D., Taras, D.: Genus VIII. Dorea. In: De Vos, P., Garrity, G. M., Jones, D., Krieg, N. R., Ludwig, W., Rainey, F. A., Schleifer, K.-H., Whitman, W. B.(eds.) The Firmicutes (Bergey´s Manual of Systematic Bacteriology; Vol. 3), Springer, 941-943 (2009).

Blaut, M., Loh, G.: Aufbau und Funktion der intestinalen Mikrobiota des Menschen. In: Bischoff, S. C. (Hrsg.) Probiotika, Präbiotika und Synbiotika. Thieme, Stuttgart-New York, S. 2-23 (2009).

Brigelius-Flohé, R., Blaut, M., Klaus, S.: Verdauung und Ernährung. In: Schartl, M., Gessler, M., von Eckardstein, A. (Hrsg.) Biochemie und Molekularbiologie des Menschen. Urban & Fischer, München, S. 862-902 (2009).

Blaut, M.: Ökologie des Darmes. In: Caspary, W. F., Kist, M., Stein, J. (Hrsg.) Infektiologie des Gastrointestinaltraktes. Springer, Berlin, S. 45-56 (2006).

Schwiertz, A., Blaut, M.: Molecular approaches in the study of gut microecology. In: Holzapfel, W. H., Naughton, P. J. (eds.) Microbial Ecology in Growing Animals. Elsevier, Amsterdam, pp 119-141 (2005).

Blaut, M.: Analysing gut microbiota. In: Remacle, C., Reusens, B. (eds.) Functional Foods, ageing, and degenerative disease. Woodhead Publishing, Cambridge, pp 325-348 (2004).

Other Papers

Schulz-Fincke, A. C., Blaut, M., Braune, A., Gutschow, M.: A BODIPY-tagged phosphono peptide as activity-based probe for human leukocyte elastase. ACS Med. Chem. Lett. 9, 345-350 (Letter) (free full text at PMC5900331) (2018).

Blaut, M.: Fördern Emulgatoren in Lebensmitteln die Entstehung von entzündlichen Darmerkrankungen und metabolischem Syndrom?. Ernaehr. Umsch. 62, M199 (2015).

Gerasimidis, K., Russell, R., Hansen, R., Quince, C., Loman, N., Bertz, M., Hanske, L., Blaut, M., McGrogan, P., Edwards, C. A.: Role of Faecalibacterium Prausnitzii in Crohn’s Disease: friend, foe, or does not really matter?. Inflamm. Bowel Dis. 20, E18-E19 (Letter) (2014).

Blaut, M.: EHEC-Bakterien auf Gemüse. Ernaehr. Umsch. 58, 390 (2011).

Blaut, M.: Mikroorganismen in der Ernährung des Menschen. 20. Hülsenberger Gespräche 2004, 125 - 132 (2004).

Scharek, L., Hartmann, L., Heinevetter, L., Blaut, M.: Bifidobacterium adolescentis suppresses the humoral immune response to an autochthonous bacterium of the intestinal flora. Berl. Münch. Tierärztl. Wochenschr. 115, 173-178 (2002).

Schwiertz, A.: Fluoreszenz-in situ-Hybridisierung in der Gastrointestinalen Mikrobiologie. transkript Laborwelt II, 13-16 (2001).

Boureau, H., Hartmann, L., Karjalainen, T., Rowland, I., Wilkinson, M. H. F.: Models to study colonisation and colonisation resistance. Microbial Ecol. Health Dis. 12, 247-258 (2000).

Kleessen, B., Bezirtzoglou, E., Mättö, J.: Culture-based knowledge on biodiversity, development and stability of human gastrointestinal microflora. Microbial Ecol. Health Dis. 12, Suppl. 2, 53-63 (2000).

Simmering, R., Schneider, H., Blaut, M.: Degradation of flavonoides by the human intestinal bacteria Eubacterium ramulus and Enterococcus casseliflavus. In: Martens, S., Treutter, D., Forkmann, G. (eds.)Polyphenols Communictions 2000. XXth International Conference on Phenols, Freising, pp 507-508 (2000).


Zunft, H.-J., Hanisch, C., Müller, S., Koebnick, C., Blaut, M., Dore, J.: Symbiotic containing Bifidobacterium animalis and inulin increases stool frequency in elderly healthy people. Asia Pac. J. Clin. Nutr. 13 (Suppl.), S112 (2004).

© 2020 DIfE - German Institute of Human Nutrition. All rights reserved. // as of 28.05.2019